Actively Recruiting
Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?
Led by New Valley University · Updated on 2024-11-21
82
Participants Needed
1
Research Sites
18 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing urethral stricture recurrence after direct visual internal urethrotomy.
CONDITIONS
Official Title
Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- American Society of Anesthesiologists (ASA) score of 3 or less
- Urethral stricture length of 1.5 cm or less
You will not qualify if you...
- Recurrent urethral stricture treated two or more times
- Pelvic fracture urethral distraction defect (PFUDD)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
New Valley University
New Valley, New Valley Governorate, Egypt, 72511
Actively Recruiting
Research Team
W
Waheed F Abdelrasol, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here